With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
As more countries rise out of poverty, CGD’s work in this area focuses on the inequities and emerging problems that jeopardize global health progress.
As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally and equitably? How can the world advance global health security and fight infectious diseases? What can be done to address treatment inequalities between developed and developing countries? What are the benefits of, mechanisms for, and threats to, greater family planning provision? CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.
President Bush literally shoots for the stars in his 2004 budget with a 5.6 percent increase to NASA’s budget. He doesn't just want to win this fall; he wants a legacy. I wonder if he knows that Cadillac legacies are available at Pontiac prices.
The Saving One Million Lives (SOML) program for results (PforR) aims to increase the utilization and quality of high impact reproductive, child health, and nutrition interventions in Nigeria. SOML was originally created in 2012 to address Nigeria’s slow progress on improving health status and health services. Since 2015, the initiative has received assistance from the World Bank through a “cash-on-delivery” (COD) approach in which the disbursement of funds is directly linked to the achievement of specific program results. This PforR funding mechanism by the World Bank uses country systems and processes and gives health managers substantial autonomy in achieving health results. Four years into the SOML PforR’s implementation, join us to explore lessons learned.
Quality affordable generic medicines play a vital role in health systems around the world. Healthy competition from quality generic medicines can help keep prices in check—a shared concern across high-income and low- and middle-income countries. But CGD’s Working Group on the Future of Global Health Procurement found that markets for generic medicines in many low- and middle-income countries are failing. According to the final report, weak and under-resourced regulatory and quality control systems in many countries can often lead healthcare workers and patients to opt for more expensive branded medicines as a proxy for quality.
The World Bank’s Disease Control Priorities, Third Edition (DCP3) defines a model concept of essential universal health coverage (EUHC) with 218 interventions that provides a starting point for country-specific analysis of priorities. Assuming steady-state implementation by 2030, EUHC in lower-middle-income countries would reduce premature deaths by an estimated 4.2 million per year. Estimated total costs prove substantial: about 9·1% of (current) gross national income (GNI) in low-income countries and 5.2% of GNI in lower-middle-income countries.